5-hydroxymethyl tolterodine
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
The muscarinic receptors have been used as target in treatment of overactive bladder (OAB) for a long time. These patients have…
Hypothesis / aims of study Muscarinic receptor antagonists and β3 adrenoceptor agonist are the currently recommended medicines…
Hypothesis / aims of study Fesoterodine (4 or 8 mg once daily (QD)), an antimuscarinic (1), and mirabegron (25 or 50 mg QD), a β3…
Hypothesis / aims of study Medicines with different mode of actions (MOA) such as antimuscarinics and β3 agonist, are available…
Hypothesis / aims of study Tolterodine is an antimuscarinic drug and is converted to 5-HMT by the cytochrome P450 (CYP) 2D6…
Hypothesis / aims of study Fesoterodine is a relatively novel antimuscarinic agent for the treatment of overactive bladder (OAB…
Hypothesis / aims of study The urothelium is important to manifest the OAB symptoms in BOO and the expression changes of various…
Hypothesis / aims of study Pre-clinical studies in anesthetized dogs suggest that the active metabolite of fesoterodine (5…
Hypothesis / aims of study Although clinical studies suggest that many patients with overactive bladder (OAB) who are…